SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Je Wook Kang, Dae Kyeong Han, Ock Nyun Kim, Kwang Jae Lee, Effect of DA-9701 on the Normal Motility and Clonidine-induced Hypomotility of the Gastric Antrum in Rats, Journal of Neurogastroenterology and Motility, 2016, 22, 2, 304

    CrossRef

  2. 2
    Tae-Ho Maeng, Jong-Soo Lee, Effectiveness of Abdominal Manipulation Therapy in Functional Dyspepsia Patients, Journal of Korean Medicine Rehabilitation, 2015, 25, 4, 113

    CrossRef

  3. 3
    Young Kwang Shim, Ju Yup Lee, Nayoung Kim, Yo Han Park, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee, Efficacy and Safety of New Prokinetic Agent Benachio Q Solution® in Patients with Postprandial Distress Syndrome Subtype in Functional Dyspepsia: A Single-center, Randomized, Double-blind, Placebo-controlled Pilot Study, The Korean Journal of Gastroenterology, 2015, 66, 1, 17

    CrossRef

  4. 4
    Sung Eun Kim, Medical treatment of functional dyspepsia, Kosin Medical Journal, 2015, 30, 1, 1

    CrossRef

  5. 5
    Chang Seok Bang, Jong Hyeok Kim, Gwang Ho Baik, Hyo Sun Kim, Sang Hyun Park, Eun Jin Kim, Jin Bong Kim, Ki Tae Suk, Jai Hoon Yoon, Yeon Soo Kim, Dong Joon Kim, Mosapride treatment for functional dyspepsia: A meta-analysis, Journal of Gastroenterology and Hepatology, 2015, 30, 1
  6. 6
    Eamonn M M Quigley, Prokinetics in the Management of Functional Gastrointestinal Disorders, Journal of Neurogastroenterology and Motility, 2015, 21, 3, 330

    CrossRef

  7. 7
    Jong Kyu Park, Kyu Chan Huh, Cheol Min Shin, Hyuk Lee, Young Hoon Yoon, Kyung Ho Song, Byung-Hoon Min, Kee Don Choi, Current Issues in Functional Dyspepsia, The Korean Journal of Gastroenterology, 2014, 64, 3, 133

    CrossRef

  8. 8
    Hiroaki Zai, Kei Matsueda, Motoyasu Kusano, Yoshihisa Urita, Youichi Saito, Hiroki Kato, Effect of acotiamide on gastric emptying in healthy adult humans, European Journal of Clinical Investigation, 2014, 44, 12
  9. 9
    Michael Camilleri, Vincenzo Stanghellini, Current management strategies and emerging treatments for functional dyspepsia, Nature Reviews Gastroenterology & Hepatology, 2013, 10, 3, 187

    CrossRef

  10. 10
    Yong Sam Kwon, Miwon Son, DA-9701: A New Multi-Acting Drug for the Treatment of Functional Dyspepsia, Biomolecules and Therapeutics, 2013, 21, 3, 181

    CrossRef

  11. 11
    Y.-S. Jung, M.-Y. Kim, H. S. Lee, S. L. Park, K. J. Lee, Effect of DA-9701, a novel prokinetic agent, on stress-induced delayed gastric emptying and hormonal changes in rats, Neurogastroenterology & Motility, 2013, 25, 3
  12. 12
    Eamonn M. M. Quigley, Brian E. Lacy, Overlap of functional dyspepsia and GERD—diagnostic and treatment implications, Nature Reviews Gastroenterology & Hepatology, 2013, 10, 3, 175

    CrossRef

  13. 13
    K. Nagahama, Y. Matsunaga, M. Kawachi, K. Ito, T. Tanaka, Y. Hori, H. Oka, M. Takei, Acotiamide, a new orally active acetylcholinesterase inhibitor, stimulates gastrointestinal motor activity in conscious dogs, Neurogastroenterology & Motility, 2012, 24, 6
  14. 14
    Ege Altan, Tatsuhiro Masaoka, Ricard Farré, Jan Tack, Acotiamide, a novel gastroprokinetic for the treatment of patients with functional dyspepsia: postprandial distress syndrome, Expert Review of Gastroenterology & Hepatology, 2012, 6, 5, 533

    CrossRef

  15. 15
    N. M. Devanarayana, S. Rajindrajith, N. Rathnamalala, S. Samaraweera, M. A. Benninga, Delayed gastric emptying rates and impaired antral motility in children fulfilling Rome III criteria for functional abdominal pain, Neurogastroenterology & Motility, 2012, 24, 5
  16. 16
    Pantelis Oustamanolakis, Jan Tack, Dyspepsia, Journal of Clinical Gastroenterology, 2012, 46, 3, 175

    CrossRef

  17. 17
    Eun Ran Kim, Byung-Hoon Min, Sung Ok Lee, Tae Ho Lee, Miwon Son, Poong-Lyul Rhee, Effects of DA-9701, a novel prokinetic agent, on gastric accommodation in conscious dogs, Journal of Gastroenterology and Hepatology, 2012, 27, 4
  18. 18
    Michio Hongo, Shigeru Harasawa, Tetsuya Mine, Iwao Sasaki, Kei Matsueda, Motoyasu Kusano, Nobuyoshi Hanyu, Koji Nakada, Chikashi Shibata, Large-scale randomized clinical study on functional dyspepsia treatment with mosapride or teprenone: Japan Mosapride Mega-Study (JMMS), Journal of Gastroenterology and Hepatology, 2012, 27, 1
  19. You have free access to this content19
    B. E. Lacy, N. J. Talley, G. R. Locke, E. P. Bouras, J. K. DiBaise, H. B. El-Serag, B. P. Abraham, C. W. Howden, P. Moayyedi, C. Prather, Review article: current treatment options and management of functional dyspepsia, Alimentary Pharmacology & Therapeutics, 2012, 36, 1
  20. You have free access to this content20
    J. Tack, M. Camilleri, L. Chang, W. D. Chey, J. J. Galligan, B. E. Lacy, S. Müller-Lissner, E. M. M. Quigley, J. Schuurkes, J. H. Maeyer, V. Stanghellini, Systematic review: cardiovascular safety profile of 5-HT4 agonists developed for gastrointestinal disorders, Alimentary Pharmacology & Therapeutics, 2012, 35, 7
  21. 21
    Yoshikazu Kinoshita, Tsutomu Chiba, Therapeutic effects of famotidine on chronic symptomatic gastritis: subgroup analysis from FUTURE study, Journal of Gastroenterology, 2012, 47, 4, 377

    CrossRef

  22. 22
    K. Matsueda, M. Hongo, S. Ushijima, H. Akiho, A Long-Term Study of Acotiamide in Patients with Functional Dyspepsia: Results from an Open-Label Phase III Trial in Japan on Efficacy, Safety and Pattern of Administration, Digestion, 2011, 84, 4, 261

    CrossRef

  23. 23
    Jan Tack, Pieter Janssen, Emerging drugs for functional dyspepsia, Expert Opinion on Emerging Drugs, 2011, 16, 2, 283

    CrossRef

  24. 24
    Sam Ryong Jee, Hye-Kyung Jung, Byung Hoon Min, Kee Don Choi, Poong-Lyul Rhee, Young Woo Kang, Sang In Lee, Guidelines for the Treatment of Functional Dyspepsia, The Korean Journal of Gastroenterology, 2011, 57, 2, 67

    CrossRef

  25. 25
    Yao-Chun Hsu, Jyh-Ming Liou, Tzeng-Huey Yang, Wei-Lun Hsu, Hwai-Jeng Lin, Huei-Tang Wu, Jaw-Town Lin, Hsiu-Po Wang, Ming-Shiang Wu, Proton pump inhibitor versus prokinetic therapy in patients with functional dyspepsia: is therapeutic response predicted by Rome III subgroups?, Journal of Gastroenterology, 2011, 46, 2, 183

    CrossRef

  26. 26
    D. Ang, N. J. Talley, M. Simren, P. Janssen, G. Boeckxstaens, J. Tack, Review article: endpoints used in functional dyspepsia drug therapy trials, Alimentary Pharmacology & Therapeutics, 2011, 33, 6
  27. 27
    Michael Camilleri, Jan F. Tack, Current Medical Treatments of Dyspepsia and Irritable Bowel Syndrome, Gastroenterology Clinics of North America, 2010, 39, 3, 481

    CrossRef

  28. 28
    Jan Tack, Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 2010,

    CrossRef

  29. 29
    Joan Khoo, Christopher K Rayner, Karen L Jones, Michael Horowitz, Pathophysiology and management of gastroparesis, Expert Review of Gastroenterology & Hepatology, 2009, 3, 2, 167

    CrossRef

  30. 30
    Tae Ho Lee, Jeong June Choi, Dong Hee Kim, Seok Choi, Kang Ro Lee, Miwon Son, Mirim Jin, Gastroprokinetic effects of DA-9701, a new prokinetic agent formulated with Pharbitis Semen and Corydalis Tuber, Phytomedicine, 2008, 15, 10, 836

    CrossRef

  31. 31
    Monique P Curran, Dean M Robinson, Mosapride, Drugs, 2008, 68, 7, 981

    CrossRef

  32. 32
    Michael K. Herbert, Peter Holzer, Standardized concept for the treatment of gastrointestinal dysmotility in critically ill patients—Current status and future options, Clinical Nutrition, 2008, 27, 1, 25

    CrossRef

  33. 33
    Meredythe A. McNally, Nicholas J. Talley, Current treatments in functional dyspepsia, Current Treatment Options in Gastroenterology, 2007, 10, 2, 157

    CrossRef

  34. 34
    Toru Hiyama, Masaharu Yoshihara, Keitaro Matsuo, Hiroaki Kusunoki, Tomoari Kamada, Masanori Ito, Shinji Tanaka, Nobuo Nishi, Kazuaki Chayama, Ken Haruma, Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia, Journal of Gastroenterology and Hepatology, 2007, 22, 3
  35. 35
    Toru Hiyama, Masaharu Yoshihara, Keitaro Matsuo, Hiroaki Kusunoki, Tomoari Kamada, Masanori Ito, Shinji Tanaka, Kazuaki Chayama, Ken Haruma, Treatment of functional dyspepsia with serotonin agonists: A meta-analysis of randomized controlled trials, Journal of Gastroenterology and Hepatology, 2007, 22, 10
  36. 36
    L. Peyrin-Biroulet, M.-A. Bigard, Dyspepsie, EMC - Gastro-entérologie, 2006, 1, 1, 1

    CrossRef

  37. 37
    Yohei Mizuta, Saburo Shikuwa, Hajime Isomoto, Ryosuke Mishima, Yuko Akazawa, Jun-ichi Masuda, Katsuhisa Omagari, Fuminao Takeshima, Shigeru Kohno, Recent insights into digestive motility in functional dyspepsia, Journal of Gastroenterology, 2006, 41, 11, 1025

    CrossRef

  38. 38
    R. J. SAAD, W. D. CHEY, Review article: current and emerging therapies for functional dyspepsia, Alimentary Pharmacology & Therapeutics, 2006, 24, 3
  39. 39
    Hidekazu Suzuki, Toshihiro Nishizawa, Toshifumi Hibi, Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification, Journal of Gastroenterology, 2006, 41, 6, 513

    CrossRef

  40. 40
    L. Peyrin-Biroulet, M.-A. Bigard, Dyspepsie, EMC - Hépato-Gastroenterologie, 2005, 2, 2, 105

    CrossRef

  41. 41
    Zhi Liu, Ryuji Sakakibara, Takeo Odaka, Tomoyuki Uchiyama, Tomoyuki Uchiyama, Tatsuya Yamamoto, Takashi Ito, Masato Asahina, Kazuya Yamaguchi, Taketo Yamaguchi, Takamichi Hattori, Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in parkinsonian patients, Movement Disorders, 2005, 20, 6
  42. 42
    B. D. CASH, W. D. CHEY, Review article: the role of serotonergic agents in the treatment of patients with primary chronic constipation, Alimentary Pharmacology & Therapeutics, 2005, 22, 11-12
  43. 43
    Suzanne Timmons, Richard Liston, Kieran J. Moriarty, Functional Dyspepsia: Motor Abnormalities, Sensory Dysfunction, and Therapeutic Options, The American Journal of Gastroenterology, 2004, 99, 4, 739

    CrossRef

  44. 44
    JJ. Mascort, M. Marzo, P. Alonso-Coello, M. Barenys, F. Carballo, M. Fernández, LJ. Ferrándiz, X. Bonfill, JM. Piqué, Guía de práctica clínica sobre el manejo del paciente con dispepsia, Gastroenterología y Hepatología, 2003, 26, 9, 571

    CrossRef

  45. 45
    William L Hasler, Pharmacotherapy for intestinal motor and sensory disorders, Gastroenterology Clinics of North America, 2003, 32, 2, 707

    CrossRef

  46. 46
    Richard Lea, Peter J. Whorwell, Serotonergic agents in the treatment of functional gastrointestinal disorders, Current Treatment Options in Gastroenterology, 2002, 5, 4, 293

    CrossRef

  47. 47
    Paul Moayyedi, Soo Shelly, Jonathan J Deeks, Brendan Delaney, Michael Innes, David Forman, Pharmacological interventions for non-ulcer dyspepsia, The Cochrane Library,
  48. 48
    Paul Moayyedi, Soo Shelly, Jonathan J Deeks, Brendan Delaney, Michael Innes, David Forman, Pharmacological interventions for non-ulcer dyspepsia, The Cochrane Library,